TMC
Trellus Management Company’s Atara Biotherapeutics ATRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-110,000
| Closed | -$857K | – | 55 |
|
|
2022
Q2 | $857K | Buy |
110,000
+15,000
| +16% | +$117K | 1.04% | 15 |
|
|
2022
Q1 | $883K | Hold |
95,000
| – | – | 0.51% | 19 |
|
|
2021
Q4 | $1.5M | Sell |
95,000
-10,100
| -10% | -$159K | 1% | 13 |
|
|
2021
Q3 | $1.88M | Buy |
105,100
+32,044
| +44% | +$573K | 1.37% | 14 |
|
|
2021
Q2 | $1.14M | Buy |
73,056
+63,056
| +631% | +$981K | 0.78% | 26 |
|
|
2021
Q1 | $144K | Sell |
10,000
-11,900
| -54% | -$171K | 0.07% | 53 |
|
|
2020
Q4 | $430K | Sell |
21,900
-133,100
| -86% | -$2.61M | 0.35% | 43 |
|
|
2020
Q3 | $2.01M | Buy |
155,000
+5,000
| +3% | +$64.8K | 2.06% | 10 |
|
|
2020
Q2 | $2.19M | Buy |
150,000
+40,000
| +36% | +$583K | 2.37% | 8 |
|
|
2020
Q1 | $936K | Buy |
110,000
+22,127
| +25% | +$188K | 1.68% | 17 |
|
|
2019
Q4 | $1.45M | Buy |
87,873
+27,873
| +46% | +$459K | 2.42% | 10 |
|
|
2019
Q3 | $847K | Buy |
60,000
+35,000
| +140% | +$494K | 0.85% | 21 |
|
|
2019
Q2 | $503K | Buy |
+25,000
| New | +$503K | 0.68% | 40 |
|